*July 2020*

In an interview with Targeted Oncology, Balazs Halmos, MD, MS, director of the Multidisciplinary Thoracic Oncology Program and director of the Section of Thoracic Medical Oncology for Montefiore Health Systems, and first director of Clinical Cancer Genetics and professor of clinical medicine at the Albert Einstein College of Medicine, discussed the current treatment landscape of EGFR-mutant NSCLC and how this space is evolving based on recent clinical trials. Read  more.